Pfizer Bets On Monthly GLP-1 Obesity Drug To Reshape Growth Story [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Pfizer (NYSE:PFE) reported positive Phase 2b VESPER-3 data for its monthly injectable GLP-1 obesity therapy acquired from Metsera. The company outlined plans to launch an expansive late stage development program, including more than 20 pivotal studies and multiple Phase 3 trials. The GLP-1 program targets the growing obesity treatment market at a time when Pfizer is addressing revenue pressure from lower COVID-19 product demand and upcoming patent expirations. For you as an investor, this move puts obesity care more firmly at the center of Pfizer's long term story. The company is already a large, diversified pharmaceutical group, and adding a monthly GLP-1 injection gives it exposure to an area that has drawn significant attention across healthcare. The Metsera acquisition and new data update are part of a broader effort to refresh the product portfolio as older drugs face competition. What matters next is how quickly Pfizer can convert this positive mid stage data into late
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Trump administration to launch TrumpRx website for discounted drugs [Los Angeles Times (CA)]Los Angeles Times
- Bristol Myers forecasts upbeat 2026, expecting Eliquis price cut to pay off [Yahoo! Finance Canada]Yahoo! Finance Canada
- ??????????????????? - ??????????????????2026-2035? [CNET News]CNET News
- ??????????????????????????: 2032????19?8813?????????? [CNET News]CNET News
- Jim Cramer Expresses Concern About Pfizer Despite Its “Terrific Yield” [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 2/3/26 - Form 8-K
- 2/2/26 - Form 4
- 1/16/26 - Form 4
- PFE's page on the SEC website